DTX2 p.Phe54Leu
c.162T>G · rs766952685 · VCV2368679
Computational evidence
| Protein change | ||
| AlphaMissense | 0.6799 | likely pathogenic |
|---|---|---|
| REVEL | 0.099 | moderately benign-leaning |
| SaProt | LLR -4.67 | tolerated |
| ⇒ AlphaMissense calls this damaging; REVEL and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -20 | GERP -3.4 |
| Regional constraint | o/e 0.76 | unconstrained · MANE · 2,592 bp · p 1.6e-06 · regional, not allelic |
| Overall | ||
| CADD | 0.008 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.0111% | 9,007 |
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,815 |
| African / African-American | 0.00133% | 74,920 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DTX2
- Protein
- p.Phe54Leu
- Coding
- c.162T>G
- MANE Select
- NM_001102594
- dbSNP
- rs766952685
- Type
- single nucleotide variant
- Location
- chr7:76480671 (GRCh38)
- Gene constraint
- LOEUF 0.855 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 73.01 · 4 PDB
- Residue 54
- the wwe 1 domain
Similar variants
- DTX2 p.Ala422= Likely benign ★★ same type
- DTX2 p.Gly515= Likely benign ★★ same type
- DTX2 p.Pro484= Benign ★★ same type
- DTX2 p.Ala146Asp Uncertain significance ★ ⚠ same type
- DTX2 p.Ala17Thr Uncertain significance ★ ⚠ same type
- DTX2 p.Ala187Ser Uncertain significance ★ ⚠ same type
- DTX2 p.Ala195Ser Uncertain significance ★ ⚠ same type
- DTX2 p.Ala255Gly Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dtx2-p-phe54leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown